基金经理：方伟
| 单位净值:0.5197 | 净值增长率:-1.61% | 净值增长率:-1.61% | 累计净值:0.5197 | 截止日期:2026/9/11 | |
|---|---|---|---|---|---|
| 最新估值:-(-) | 涨跌幅:- | 涨跌额:- | |||
| 最新规模:0.1亿元 | 风险等级:中高风险 | 申购状态:可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
银河医药混合C(015666)资产配置 |
|||||
|---|---|---|---|---|---|
| 报告日期 | 股票(元) | 债券(元) | 基金总资产(元) | 基金净值(元) | 股票占净值比 |
| 2026/6/30 | 340,118,000 | - | 363,083,000 | 360,707,000 | 94% |
| 2026/3/31 | 437,826,000 | - | 469,743,000 | 463,833,000 | 94% |
| 2025/12/31 | 407,612,000 | - | 436,115,000 | 433,694,000 | 94% |
| 2025/9/30 | 476,503,000 | - | 509,786,000 | 506,120,000 | 94% |
| 2025/6/30 | 462,177,000 | - | 495,454,000 | 494,130,000 | 94% |
| 2025/3/31 | 461,091,000 | - | 498,636,000 | 496,543,000 | 93% |
| 2024/12/31 | 456,161,000 | - | 485,414,000 | 484,067,000 | 94% |
| 2024/9/30 | 500,005,000 | - | 538,366,000 | 537,324,000 | 93% |
| 2024/6/30 | 438,748,000 | - | 472,830,000 | 471,545,000 | 93% |
| 2024/3/31 | 469,870,000 | - | 505,107,000 | 504,088,000 | 93% |
| 2023/12/31 | 567,734,000 | - | 604,065,000 | 602,714,000 | 94% |
| 2023/9/30 | 594,674,000 | - | 632,679,000 | 631,488,000 | 94% |
| 2023/6/30 | 655,747,000 | - | 705,432,000 | 697,402,000 | 94% |
| 2023/3/31 | 739,433,000 | - | 789,046,000 | 785,801,000 | 94% |
| 2022/12/31 | 759,353,000 | - | 829,368,000 | 819,559,000 | 93% |
| 2022/9/30 | 711,778,000 | - | 757,650,000 | 755,653,000 | 94% |
| 2022/6/30 | 843,258,000 | - | 907,711,000 | 899,281,000 | 94% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。